Caladrius Biosciences

$1.60
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

$0.00 (0.00%) Today
-$0.01 (-0.62%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell CLBS and other stocks, options, and ETFs commission-free!

About CLBS

Caladrius Biosciences, Inc. Common Stock, also called Caladrius Biosciences, is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases.

CEO
David J. Mazzo
Employees
24
Headquarters
Basking Ridge, New Jersey
Founded
1980
Market Cap
103.03M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.35M
High Today
$1.67
Low Today
$1.59
Open Price
$1.59
Volume
889.14K
52 Week High
$4.89
52 Week Low
$1.25

CLBS Earnings

-$0.47
-$0.31
-$0.16
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 6, After Hours

You May Also Like

ESGRO
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure